Keyword: Boehringer Ingelheim
News
15.09.2021
-
ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...
News
06.09.2021
-
ISPE and its members are developing the roadmap to introduce Industry 4.0, also called the Smart Factory, at the pharmaceutical industry as Pharma 4.0 – an operating...
News
13.08.2021
-
Finnish nanoparticle medicine specialist Nanoform and German drugmaker Boehringer Ingelheim have agreed to collaborate on proof-of-concept studies related to Nanoform’s...
News
25.01.2021
-
German drugmaker Boehringer Ingelheim and UK biotech Enara Bio have agreed to collaborate on the research and development of novel targeted cancer immunotherapies...
News
23.11.2020
-
German privately owned drugmaker Böhringer Ingelheim has reached an agreement in principle to settle nearly 3,000 US lawsuits alleging that its Pradaxa (dabigatran...
Chemistry & Life Sciences
31.08.2020
-
Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...
Plant Construction & Process Technology
14.04.2020
- Established in 2004 by the International Society for Pharmaceutical Engineering (ISPE), the Facility of the Year Awards (FOYA) recognize innovation and creativity in manufacturing...
Markets & Companies
13.09.2019
- Abbvie takes over Allergan, Pfizer merges its generics business with Mylan, Takeda integrates Shire — the pharmaceutical industry is making a name for itself in 2019 with several...